Ercros, S.A. (BME:ECR)

Market Cap	246.88M
Revenue (ttm)	654.67M
Net Income (ttm)	-42.32M
Shares Out	91.44M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (3.46%)
Ex-Dividend Date	n/a

Volume	31,511
Average Volume	38,897
Open	2.700
Previous Close	2.700
Day's Range	2.675 - 2.700
52-Week Range	2.580 - 3.750
Beta	0.67
RSI	37.46
Earnings Date	Aug 28, 2025

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s prod...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,318
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR